Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/02/2026 | Q4 | $4B | -- | -- | $13.09 | -- |
| 10/27/2025 | Q3 | $3.8B | $4.3B | $6.09 | $14.52 | -$8.43 |
| 07/30/2025 | Q2 | $4.1B | $4.5B | $16.08 | $14.82 | $1.25 |
| 04/30/2025 | Q1 | $3.9B | $4.3B | $4.92 | $7.74 | -$2.83 |
| 02/03/2025 | Q4 | $4B | $4.6B | -$13.60 | -$17.42 | $3.82 |
| 10/30/2024 | Q3 | $4.2B | $4.3B | $11.81 | $11.73 | $0.08 |
| 07/31/2024 | Q2 | $4.3B | $4.2B | $16.71 | $16.64 | $0.07 |
| 04/30/2024 | Q1 | $4.1B | $4.1B | $16.90 | $16.03 | $0.87 |
| 02/07/2024 | Q4 | $3.7B | $3.7B | $18.53 | $14.65 | $3.87 |
| 10/25/2023 | Q3 | -- | $4B | $15.64 | -- | -- |
| 07/26/2023 | Q2 | -- | $3.7B | $16.27 | -- | -- |
| 05/01/2023 | Q1 | -- | $3.3B | $9.30 | -- | -- |
| 12/31/2022 | Q4 | -- | $3.3B | $12.72 | -- | -- |
| 09/30/2022 | Q3 | -- | $3.1B | -$8.22 | -- | -- |
| 06/30/2022 | Q2 | -- | $2.8B | $3.11 | -- | -- |
| 03/31/2022 | Q1 | -- | $2.9B | $7.56 | -- | -- |
| 12/31/2021 | Q4 | -- | $3.1B | $10.83 | -- | -- |
| 09/30/2021 | Q3 | -- | $2.9B | -$1.88 | -- | -- |
| 06/30/2021 | Q2 | -- | $3.1B | $16.95 | -- | -- |
| 03/31/2021 | Q1 | -- | $2.7B | $8.52 | -- | -- |
| 12/31/2020 | Q4 | -- | $2.8B | $1.57 | -- | -- |
| 09/30/2020 | Q3 | -- | $2.6B | $6.07 | -- | -- |
| 06/30/2020 | Q2 | -- | $2.2B | $4.77 | -- | -- |
| 03/31/2020 | Q1 | -- | $2B | $0.41 | -- | -- |
| 12/31/2019 | Q4 | -- | $2.2B | $5.27 | -- | -- |
| 09/30/2019 | Q3 | -- | $2B | $2.56 | -- | -- |
| 06/30/2019 | Q2 | -- | $2B | $8.15 | -- | -- |
| 03/31/2019 | Q1 | -- | $2B | $8.67 | -- | -- |
| 12/31/2018 | Q4 | -- | $1.8B | -$9.38 | -- | -- |
| 09/30/2018 | Q3 | -- | $1.9B | $4.84 | -- | -- |
| 06/30/2018 | Q2 | -- | $1.9B | $1.70 | -- | -- |
| 03/31/2018 | Q1 | -- | $1.7B | $5.11 | -- | -- |
| 12/31/2017 | Q4 | -- | $1.9B | $13.85 | -- | -- |
| 09/30/2017 | Q3 | -- | $1.7B | -$15.73 | -- | -- |
| 06/30/2017 | Q2 | -- | $1.5B | $5.95 | -- | -- |
| 03/31/2017 | Q1 | -- | $1.5B | $7.07 | -- | -- |
| 12/31/2016 | Q4 | -- | $1.6B | $9.04 | -- | -- |
| 09/30/2016 | Q3 | -- | $1.5B | $7.06 | -- | -- |
| 06/30/2016 | Q2 | -- | $1.4B | $3.67 | -- | -- |
| 03/31/2016 | Q1 | -- | $1.2B | $4.00 | -- | -- |
| 12/31/2015 | Q4 | -- | $1.6B | $8.26 | -- | -- |
Everest Group Ltd. reported $4.3B worth of top line sales in its most recent quarter.
Everest Group Ltd. announced earnings per share of $6.09 which represents a miss of analyst forecast a $14.52 per share.
Everest Group Ltd. reported -- that represents -- per share over the last quarter.
Everest Group Ltd.'s earnings are forecast to grow from $31.80 per share to $30.39 per share next year representing an increase of 40.43%.
Everest Group Ltd.'s next earnings date is February 2, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.